Major surgery is associated with an increased risk of post-operative immunosuppression and infections. We investigated the influence of influenza vaccination on cell-mediated immune responses in cancer patients undergoing either surgical or conservative therapy. Forty patients with an upper aerodigestive tract tumour were allocated to either a surgical or non-surgical treatment course. Patients within each group were randomized to the vaccination or nonvaccination group. Vaccination was performed twice before surgery or conservative treatment. Human leucocyte antigen receptor (HLA-DR) expression on monocytes was analysed by flow cytometry.
Introduction
Patients with an upper aerodigestive tract tumour either undergo surgery or conservative treatment, i.e. radio-chemotherapy depending on the tumour stage. As a result of suppression of cell-mediated immune reactivity, 1 both these interventions expose the patient to an increased risk of infection-related complications, such as pneumonia or surgical site infections. In addition, an inadequate whole blood cell response following surgery, reflecting a shift in immune balance towards an anti-inflammatory response, and increased post-operative infection rates have been CD Spies, M Kip, A Lau et al. Enhanced HLA-DR expression after vaccination reported. 2 Furthermore, low interleukin-6/interleukin-10 (IL-6/IL-10) ratios have been associated with a significantly increased postoperative infection rate. 3 The immune response to tissue injury can be divided into innate and acquired responses. 4 The innate immune system mounts the initial response, which includes activation of macrophages/monocytes, natural killer (NK) cells and neutrophils, while the acquired immune system response is first triggered by presentation of foreign antigens to CD4+ and CD8+ T cells. The CD4+ T cell activation leads to cytokine production, which itself amplifies the innate and acquired immune system responses. 5 It is well known that surgery causes a shift toward a reduced T-helper 1/T-helper 2 (Th1/Th2) ratio. 6 In addition, Haupt et al. 7 demonstrated reduced reactivity of circulating monocytes following stimulation with bacteria or endotoxin after surgical trauma. This abrogation of monocyte cell function has been reported to persist for 3 -5 days after surgery or trauma. 8 A decreased antigen-presenting capacity by monocytes is considered to be relevant for depressed cellmediated immune reactivity in patients following major surgery. 9, 10 In addition, impaired monocyte function and monocyte-T cell interactions have been shown to be crucial in the development of infectious and septic complications in the surgical patient. 11 Human leucocyte antigen (HLA-DR) receptor expression is depressed in surgical patients with post-operative infections 12 and it has been shown to correlate with the severity of sepsis and outcome. 13 -15 Vaccination can enhance the HLA-DR response. 16 In immunocompromised patients with cancer, there is convincing evidence that vaccination can be used safely. 17, 18 Little is known, however, about the effect of vaccination on cell-mediated immune reactivity in cancer patients undergoing surgery. In order to address this issue we have, to the best of our knowledge, undertaken the first study to investigate the effect of vaccination on monocyte HLA-DR expression and lymphokine release in patients with an upper aerodigestive tract tumour undergoing surgery or conservative treatment.
Patients and methods

PATIENTS
The study evaluated consecutive patients of American Society of Anesthesiologists (ASA) classification I -III who had an upper aerodigestive tract tumour for potential inclusion in this randomized prospective pilot study. Patients were excluded if < 18 years old, pregnant or lactating, were of ASA classification IV or V, had any diagnosed infection in the previous 14 days, were HIV positive, had liver cirrhosis (Child B or C), had undergone organ transplantation, were immune suppressed (i.e. treatment with corticosteroids in the previous 4 weeks), had an unclear alcohol history, had a known incompatibility or allergy against any component of the vaccine or had a significant psychiatric illness.
This study was approved by the institutional ethical committee of Charité-University Medicine Berlin and patients were enrolled in this study after written informed consent was obtained.
GROUP ASSIGNMENT
Patients were randomly assigned to either the vaccination group or the nonvaccination group. A separate subgroup analysis of the surgical patients was planned a priori. Patients undergoing surgery were anaesthetized according to our standard operating procedures. 19 
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INVESTIGATIONAL PROTOCOL AND MEASUREMENTS
Immediately after admission to hospital, key patient characteristics (age, gender, body mass index [BMI], current smoking status) were documented. Comorbidities, including arterial hypertension, chronic obstructive pulmonary disease (COPD), insulin-dependent and noninsulin-dependent diabetes mellitus, obesity, presence of infective hepatitis, allergies as well as alcohol use disorders (AUDs) were also documented. AUDs were diagnosed as previously described. 20, 21 Patients in the vaccination group undergoing surgery were vaccinated twice before surgery: the first vaccination was performed after blood sampling (baseline) 3 days before surgery; the second vaccination was performed after blood sampling immediately before surgery. Patients in the vaccination group that underwent conservative treatment were also vaccinated twice at time points that corresponded with those used for the surgical patients ( Fig. 1 ). Blood samples were drawn according to the study protocol at baseline prior to the first vaccination and on day 1 after surgery (which was day 4 for the non-surgical patients) and day 3 after surgery (which was day 5 for the non-surgical patients) ( Fig. 1 ). 
VACCINATION
HLA-DR EXPRESSION ON MONOCYTES
For the flow cytometric analysis of HLA-DR expression, 50 µl of whole blood in a Vacutainer ® tube containing ethylenediaminetetra-acetic acid (EDTA) was stained with 20 ml of monoclonal phycoerythrin (PE) conjugated anti-HLA-DR and PerCP-Cy5.5 conjugated anti-CD14 antibodies (all Quantibrite™, Becton Dickinson Biosciences, FIGURE 1: Study protocol for vaccination and taking of blood samples for the surgical and non-surgical (control) patients with upper aerodigestive tract tumour (n = 40). Key: I, baseline (day 1) -blood samples taken prior to vaccination and first vaccination given; II, second vaccination given and, for surgical patients, this is the day of surgery; III, blood samples taken; IV, blood samples taken 
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San Jose, CA, USA) in the dark at room temperature for 30 min. For erythrocyte lysis, the samples were incubated with 0.5 ml fluorescence-activated cell sorter (FACS) lysing solution (Becton Dickinson Biosciences) for a further 30 min at room temperature in the dark. Subsequently, the cells were washed with 1 ml of FACS buffer and analysed on a FACSCalibur cytometer (Becton Dickinson Biosciences) after Quantibrite™ calibration for 1:1 quantification.
SURFACE EXPRESSION OF CD4
Surface expression of CD4 was measured using labelled monoclonal antibodies, a FACScan ® cytometer and Lysys II ® software (all from Becton Dickinson, Heidelberg, Germany).
EX VIVO LYMPHOKINE SECRETION BY WHOLE BLOOD CELLS
To determine cytokine secretion by whole blood cells, peripheral blood mononuclear cells (PMBCs; 1 × 10 6 cells/ml) in RPMI 1640 medium supplemented with 10% fetal calf serum and 2 mM glutamine were stimulated with 100 µg/ml whole blood concanavalin A (Con A) (Serva, Heidelberg, Germany) over 24 h. Interferon-γ (IFN-γ) and IL-10 were measured in the supernatant by enzymelinked immunosorbent assay (Biosource, Camarillo, CA, USA).
POST-OPERATIVE COURSE
The intensive care unit (ICU) and hospital stays were documented. The overall complication rate, which included infections, cardiopulmonary insufficiency, delirium, bleeding and other surgical complications, was recorded. All infections were diagnosed according to criteria recommended by the Centers for Disease Control and Prevention. 22 In the case of nosocomial pneumonia, the diagnosis was made if systemic signs of infection were present, new or worsening infiltrates were seen on the chest X-ray, and new onset of purulent sputum or a change of sputum with bacteriological evidence was found. 23, 24 A surgical wound infection was diagnosed if the infection occurred within 30 days of the operative procedure and if the patient had at least one of the following criteria: purulent material draining from either the superficial or deep aspect of the incision, organisms isolated from an aseptically obtained deep or superficial wound swab, and at least one of the following signs or symptoms: pain, tenderness, swelling, redness, heat or a history of AUD.
STATISTICAL ANALYSIS
All data are expressed as frequencies and percentages or median and quartiles. All immune parameters with respect to time were analysed using non-parametric multivariate analysis of variance for repeated measurements. A two-factorial design was used where the first factor was the group, comprising the surgical stratum of vaccination group versus non-vaccination group and the non-surgical stratum of vaccination group versus non-vaccination group and the second factor was time. 25 The Mann-Whitney U-test and Fisher's exact test, respectively, were used. A P-value < 0.05 was considered significant. The numerical calculations were carried out with SAS ® for Windows ® , release 8.02 (SAS Institute Inc., Cary, NC, USA).
Results
PATIENTS
A total of 67 patients with an upper aerodigestive tract tumour were evaluated for their potential inclusion in this randomized prospective pilot study ( Fig. 2 ). Of these the tumour proved to be benign at diagnostic panendoscopy in four cases and 15 patients chose not to participate in the Loss of follow up n = 2 Refused blood draw study. In total, therefore, 48 patients were enrolled in this study and randomized to one of two treatment groups. Eight patients were excluded following enrolment for the reasons shown in Fig. 2 , so the data from 40 patients were included in the final analysis. Patient characteristics, tumour classification and comorbidities did not differ between the two groups (Table 1) . No serious adverse events were observed during this study.
HLA-DR EXPRESSION ON MONOCYTES
In the non-surgical patients, monocyte HLA-DR expression increased significantly in the vaccination group compared with the nonvaccination group (P = 0.016; Fig. 3) , whereas in the patients that underwent surgery, HLA-DR expression significantly decreased in both the vaccination (P < 0.05) and non-vaccination groups (P < 0.05) until day 3 after surgery 
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compared to baseline, but the extent of this decrease was not different between the two groups ( Fig. 3) . One patient in the vaccination group who underwent surgery showed immune suppression with a monocyte HLA-DR expression of 4387 antibodies per cell on day 3 after surgery, which was not associated with any infectious complication. In the nonvaccination group, two patients experienced immune suppression following surgery with HLA-DR expressions of 3313 antibodies per cell on day 1 after surgery and 4584 antibodies per cell on day 3 after surgery, respectively; this immune suppression was clinically associated with pneumonia in one patient.
SURFACE EXPRESSION OF CD4
In patients undergoing surgery, surface expression of CD4 significantly decreased after surgery compared with baseline (P < 0.05) in both the non-vaccination and vaccination groups, but there was no significant betweengroup differences (Fig. 4) . In those patients that were treated conservatively, the surface expression of CD4 was not influenced by vaccination (Fig. 4 ).
IFN-γ/IL-10 LYMPHOKINE RATIO
Patients treated with or without surgery showed no differences with respect to the lymphokine IFN-γ/IL-10 ratio between the vaccination and non-vaccination groups (Fig. 5 ).
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POST-OPERATIVE COURSE
The overall complication rate, including pneumonia, wound infection and bleeding complications, did not differ between the vaccination and non-vaccination groups for patients treated with and without surgery. In particular, two patients treated with surgery in the non-vaccination group developed infections (pneumonia, n = 1; wound infection, n = 1) versus three patients in the vaccination group (pneumonia, n = 2; wound infections, n = 1). All patients in the non-vaccination group and seven patients in the vaccination group were admitted to the ICU immediately after surgery. The median (range) length of stay in the ICU for the non-vaccination group was 2 (1 -4) days versus 2 (1 -5) days for the vaccination group. The overall hospital stay for the non-surgical patients and the overall post-operative hospital stay for the surgical patients did not differ significantly between the groups ( Table 2) . One patient in the non-vaccination group died on the 16th post-operative day in the ICU after septic complications. The out-ofhospital mortality rate after 2 years did not differ significantly between vaccinated (39%) and non-vaccinated patients (41%) ( Table 2 ).
Discussion
To the best of our knowledge this is the first study to investigate the influence of vaccination on monocyte HLA-DR expression and lymphokine production in cancer patients undergoing surgical or conservative treatment. The rationale for including nonsurgical patients was to have a comparable control group without surgical stimulus or exposure to anaesthesia, both of which are known to affect cell-mediated immune responses. 20, 26, 27 In the present study, vaccination enhanced 303 HLA-DR expression in conservatively-treated patients with cancer of the upper aerodigestive tract, whereas this effect did not extend to patients undergoing surgery. In addition, T cell mediated lymphokine release was not affected by vaccination. The out-ofhospital 2-year mortality rate did not differ between the vaccination and non-vaccination groups.
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Studies have addressed the impact of immune therapy on restoring monocyte function and increasing HLA-DR monocyte expression. 16 
on monocytes after influenza vaccination in children after haemopoietic stem cell transplantations. These findings were partly in accordance with our results regarding the non-surgical patients which suggest that enhanced HLA-DR expression after vaccination in conservatively-treated cancer patients might improve host defence in these patients, whereas surgery per se might abrogate this effect.
In our study, infection rates in the surgical patients treated with and without vaccination were identical, whereas no infection occurred in the patients treated conservatively. Despite the fact that the clinical relevance of HLA-DR expression on monocytes remains controversial, 28, 29 the results of our pilot study favour the hypothesis that cancer patients undergoing surgery might benefit from vaccination in the post-operative period, although this remains to be confirmed in further investigations.
In our present study, the IFN-γ/IL-10 lymphokine ratio in whole blood did not differ between groups nor was there any difference between the surgical and nonsurgical patients after subgroup analysis. Our results regarding patients that underwent surgery in the non-vaccination group were in accordance with previous findings. 2, 3 Reduced IFN-γ/IL-10 ratios in lipopolysaccharide-stimulated whole blood cells on day 1 after surgery in long-term alcoholic patients with a tumour of the upper digestive tract have been found to be associated with an increased post-operative infection rate. 2, 3 Only a few studies have investigated the influence of vaccination on cell-mediated immune reactivity. 16, 18 Avetisyan et al. 18 demonstrated that healthy immunocompetent individuals responded to influenza vaccination with increased numbers of IFN-γ producing helper T-lymphocytes, which is in contrast to our findings. This difference in findings might be due to different clinical settings (nonsurgical patients without cancer). Haining et al. 16 investigated specific T-cell responses to vaccination with influenza A antigen in patients following haemopoietic stem cell transplantation. Following vaccination, CD4+ proliferation increased significantly in all patients from a mean of 3.3% to 19.0%. 16 The authors concluded that the cellular response may be a more sensitive measure of vaccine-elicited immunity than antibody levels in immunocompromised individuals. 16 In our present study, however, we were not able to confirm these results, which might be attributed to a different study design (vaccination at 3 and 21 months after poststem cell transplantation versus vaccination during the early post-operative period) and patient population (children with haemopoietic stem cell transplantation versus adults with cancer). However, CD4+ proliferation was not the aim of our study and T-cell mediated immune responses, measured in terms of lymphokine release, were not affected in our study.
The present study has several limitations that should be mentioned. First, this was a pilot study and was not intended to differentiate between patients with and without AUDs. We cannot conclude, therefore, whether concomitant AUDs might have influenced immune parameters at all time points due to the fact that pre-operative immunosuppression and an altered response to surgical stress have been found in chronic alcoholics. 29, 30 We did find, however, that the response to vaccination did not differ between patients with and without AUDs in our study. Secondly, we documented the outof-hospital 2-year mortality rate to describe the long-term effect of vaccination in cancer patients, but the number of patients enrolled CD Spies, M Kip, A Lau et al. Enhanced HLA-DR expression after vaccination in this pilot study was not sufficient to investigate this parameter adequately. The long-term outcome after vaccination needs to be better characterized in further clinical trials, however this pilot study suggests that vaccination was safe and that the out-ofhospital 2-year mortality rate did not differ between vaccinated and non-vaccinated patients.
In conclusion, this pilot study demonstrated for the first time that surgery abolishes the enhanced HLA-DR expression that is induced by vaccination with influenza haemagglutinin antigens. Vaccination after surgery might, therefore, warrant further investigation in surgically-treated cancer patients in terms of it restoring HLA-DR expression and lymphokine release.
